Abstract:BACKGROUND:Vascular growth followed by vessel specification is crucial for the establishment of a hierarchical blood vascular network. We have shown that TIE2 is required for vein development while little is known about its homologue TIE1 (tyrosine kinase with immunoglobulin-like and EGF [epithelial growth factor]-like domains 1) in this process. METHODS:We analyzed functions of TIE1 as well as its synergy with TIE2 in the regulation of vein formation by employing genetic mouse models targeting Tie1, Tek, and Nr2f2, together with in vitro cultured endothelial cells to decipher the underlying mechanism. RESULTS:Cardinal vein growth appeared normal in TIE1-deficient mice, whereas TIE2 deficiency altered the identity of cardinal vein endothelial cells with the aberrant expression of DLL4 (delta-like canonical Notch ligand 4). Interestingly, the growth of cutaneous veins, which was initiated at approximately embryonic day 13.5, was retarded in mice lack of TIE1. TIE1 deficiency disrupted the venous integrity, displaying increased sprouting angiogenesis and vascular bleeding. Abnormal venous sprouts with defective arteriovenous alignment were also observed in the mesenteries of Tie1-deleted mice. Mechanistically, TIE1 deficiency resulted in the decreased expression of venous regulators including TIE2 and COUP-TFII (chicken ovalbumin upstream promoter transcription factor, encoded by Nr2f2, nuclear receptor subfamily 2 group F member 2) while angiogenic regulators were upregulated. The alteration of TIE2 level by TIE1 insufficiency was further confirmed by the siRNA-mediated knockdown of Tie1 in cultured endothelial cells. Interestingly, TIE2 insufficiency also reduced the expression of TIE1. Combining the endothelial deletion of Tie1 with 1 null allele of Tek resulted in a progressive increase of vein-associated angiogenesis leading to the formation of vascular tufts in retinas, whereas the loss of Tie1 alone produced a relatively mild venous defect. Furthermore, the induced deletion of endothelial Nr2f2 decreased both TIE1 and TIE2. CONCLUSIONS:Findings from this study imply that TIE1 and TIE2, together with COUP-TFII, act in a synergistic manner to restrict sprouting angiogenesis during the development of venous system.

DOT1L Promotes Angiogenesis Through Cooperative Regulation of VEGFR2 with ETS-1

Endothelial TIE1 Restricts Angiogenic Sprouting to Coordinate Vein Assembly in Synergy with Its Homologue TIE2

Endothelial CDS2 deficiency causes VEGFA-mediated vascular regression and tumor inhibition

Common and distinct functions of mouse Dot1l in the regulation of endothelial transcriptome

Angiomotin-Like2 Gene (amotl2) is Required for Migration and Proliferation of Endothelial Cells During Angiogenesis

Epigenetic priming by Dot1l in lymphatic endothelial progenitors ensures normal lymphatic development and function

DCBLD1 Modulates Angiogenesis by Regulation of the VEGFR-2 Endocytosis in Endothelial Cells

Soluble delta-like 1 homolog (DLK1) stimulates angiogenesis through Notch1/Akt/eNOS signaling in endothelial cells

NEDD4L is a promoter for angiogenesis and cell proliferation in human umbilical vein endothelial cells

DCBLD1 modulates angiogenesis by regulating of the VEGFR-2 endocytosis in endothelial cells

The pro-angiogenesis effect of miR33a-5p/Ets-1/DKK1 signaling in ox-LDL induced HUVECs

VEGF Amplifies Transcription Through ETS1 Acetylation to Enable Angiogenesis.

RNF20-mediated transcriptional pausing and VEGFA splicing orchestrate vessel growth

DLK1 Promoted Ischemic Angiogenesis Through Notch1 Signaling in Endothelial Progenitor Cells

DOT1L Epigenetically Regulates Autophagy and Mitochondria Fusion in Cell Lines of Renal Cancer.

LMO2 Regulates Angiogenesis Through TGFB1 and HGF

DOT1L Affects Colorectal Carcinogenesis Via Altering T Cell Subsets and Oncogenic Pathway

DOT1L Promotes Cell Proliferation and Invasion by Epigenetically Regulating STAT5B in Renal Cell Carcinoma.

SUMOylation Negatively Regulates Angiogenesis by Targeting Endothelial NOTCH Signaling.

DNMT3A inhibits E2F1-induced arterial marker expression and impairs angiogenesis in human umbilical artery endothelial cells

DOT1L Complex Regulates Transcriptional Initiation 1 in Human Cells